ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,554.25
      0.20%
      US Tech 100
      18,971.20
      -0.03%
      Dow Jones
      40,659.76
      0.24%
      Brent Oil
      78.74
      -0.12%
      Bitcoin
      58,558.96
      0.17%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Madrigal Pharmaceuticals Inc (MDGL)

      7. Madrigal Pharmaceuticals Inc (MDGL) Financials

      Madrigal Pharmaceuticals Inc

      Madrigal Pharmaceuticals Inc (MDGL)

      NASDAQ
      250.81
      6.31
      (2.58%)
      Closed August 19 4:00PM
      Delayed by 15 minutes
      251.37
      0.56
      (0.22%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Madrigal Pharmaceuticals Inc Financial Summary

      The current MDGL market cap is 5.45B. The company's latest EPS is USD -17.2079 and P/E is -14.61.

      Income Statement

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 000014.64M
      Operating Income -86.45M-98.53M-117.18M-152.04M-162.54M
      Net Income -85.8M-98.74M-112.19M-147.54M-151.97M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 00000
      Operating Income -94.97M-206.67M-242.48M-293.57M-380.5M
      Net Income -83.95M-202.24M-241.85M-295.35M-373.63M

      Balance Sheet

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 302.46M237.96M640.55M1.08B1.1B
      Total Liabilities 198.96M215.72M235.21M231.52M242.67M
      Total Equity 103.51M22.25M405.33M850.76M857.12M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 442.06M287M273.33M362.57M640.55M
      Total Liabilities 25.49M47.03M77.23M165.18M235.21M
      Total Equity 416.57M239.97M196.11M197.39M405.33M

      Cash Flow

      Annual Quarterly
      Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -159.38M-244.3M-324.23M-149.16M-284.1M
      Investing -190.6M-140.4M-502.52M98.05M-24.05M
      Financing 95.62M115.2M595.12M573.71M707.83M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -41.62M-157.56M-183.92M-224.86M-324.23M
      Investing 30.71M159.78M-5.06M206.69M-502.52M
      Financing 235k5.09M171.24M313.45M595.12M

      Stats and Ratios

      Market Cap 5.45B
      Price to Earnings Ratio -14.61
      Price to Sales Ratio 0
      Price to Cash Ratio 54.63
      Price to Book Ratio 13.47
      Dividend Yield -

      Share Statistics

      Shares Outstanding 21.71M
      Average Volume (1 week) 256.56k
      Average Volume (1 Month) 318.55k
      52 Week Change 44.28%
      52 Week High 298.00
      52 Week Low 119.7604
      Spread (Intraday) 14.79 (5.87%)

      Company Info

      Company Name Madrigal Pharmaceuticals Inc
      Address 2711 centerville road
      wilmington, delaware 19808
      Website https://www.madrigalpharma.com
      Industry pharmaceutical preparations (2834)